An Analytical Reference Standard
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

N-Pyrrolidino Metonitazene (citrate)

Item No. 37685

Synonyms
Synonyms
  • Metonitazepyne
Technical Information
Formal Name
2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo[d]imidazole, 2-hydroxy-1,2,3-propanetricarboxylate
Molecular Formula
C21H24N4O3 • C6H8O7
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 3 mg/mlDMSO: 3 mg/ml
λmax
243 nm
SMILES
COC(C=C1)=CC=C1CC2=NC3=CC([N+]([O-])=O)=CC=C3N2CCN4CCCC4.OC(CC(O)=O)(C(O)=O)CC(O)=O
InChi Code
InChI=1S/C21H24N4O3.C6H8O7/c1-28-18-7-4-16(5-8-18)14-21-22-19-15-17(25(26)27)6-9-20(19)24(21)13-12-23-10-2-3-11-23;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-9,15H,2-3,10-14H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
InChi Key
AIPDICOXJFKNKF-UHFFFAOYSA-N
Regulatory Information
DEA Schedule
I
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    N-Pyrrolidino metonitazene (citrate) (Item No. 37685) is an analytical reference standard categorized as an opioid.1 N-Pyrrolidino metonitazene is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kozell, L.B., Eshelman, A., J., Wolfrum, K.M., et alPharmacologic characterization of substituted nitazenes at μ, κ, and Δ opioid receptors suggests high potential for toxicity. J. Pharmacol. Exp. Ther. 389(2), 219-228 (2024).

    Product Citations

    Sapkota, R., Lomnicki, E.E., and Subedi, B. Nitazenes discharged during Super Bowl and Mardi Gras celebrations in New Orleans, USA. Environ. Sci. Tech. Lett. (2026).

    Truver, M.T., Roman, M., Gomonit, M.M., et alFatal intoxications with nitazenes: Postmortem findings, toxicology, and in vitro characterization at the μ-opioid receptor of six nitazene analogues. Arch. Toxicol. (2026).

    Hardwick, E.K., and Davidson, J.T. Structural characterization of nitazene analogs using electrospray ionization-tandem mass spectrometry (ESI-MS/MS). Drug Test Anal. (2025).

    Berardinelli, D., Taoussi, O., Ovat, D.Y., et alHuman metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations. Arch. Toxicol. (2025).

    Kozell, L.B., Eshelman, A., J., Wolfrum, K.M., et alPharmacologic characterization of substituted nitazenes at μ, κ, and Δ opioid receptors suggests high potential for toxicity. J. Pharmacol. Exp. Ther. 389(2), 219-228 (2024).